# Correction: Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

**Authors:** Melchiorre Cervello, Dimcho Bachvarov, Nadia Lampiasi, Antonella Cusimano, Antonina Azzolina, James A. McCubrey, Giuseppe Montalto

PMC · DOI: 10.1371/journal.pone.0335701 · 2025-11-03

## Full-text entities

- **Diseases:** Liver Cancer (MESH:D006528)
- **Chemicals:** Sorafenib (MESH:D000077157), Celecoxib (MESH:D000068579)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12582416/full.md

---
Source: https://tomesphere.com/paper/PMC12582416